Neuroimaging – News and Features

The collaboration focuses development of imaging and diagnostic technologies using genomics, proteomics, and integrated research and clinical care.

LabCorp enters into an exclusive license agreement to commercialize Duke's new blood-based assay for early detection of lung cancer.

In a study comparing brain activity of sober alcoholics and non-addicted people making financial decisions, the group of sober alcoholics showed more impulsive neural activity.

Multi-site clinical trial to study GM-I’s LumaGEM® Molecular Breast Imaging (MBI) technology for early detection, diagnosis and treatment of breast cancer.

The multi-institutional study will seek to identify the genetic, epidemiological and radiological characteristics of COPD to find more effective treatments.

Early clinical data supporting use of Aastrom Bone Repair Cells (BRCs) in treatment of osteonecrosis of the femoral head also presented.

The study used positron-emission tomography and bioluminescent imaging to quantify biodistribution and function in mice of siRNA nanoparticles formulated with Calando's proprietary polymer technology for delivering siRNA and other nucleic acids.

Software to save years in research that aligns patients and treatments.

Data demonstrate human cardiac cell survival in infarct zone, resulting in improved cardiac structure and contractile function.

Brain areas that control attention were thinnest in children with attention deficit hyperactivity disorder who carried a particular version of a gene in a study by NIMH.